SEATTLE (AP) — SEATTLE (AP) — Perspective Therapeutics, Inc. (CATX) on Tuesday reported a loss of $15.1 million in its third quarter.
On a per-share basis, the Seattle-based company said it had a loss of 21 cents.
The results matched Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was also for a loss of 21 cents per share.
The isotope-based medical products maker posted revenue of $369,000 in the period.
Perspective Therapeutics shares have more than doubled since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $10.75, more than quadrupling in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CATX at https://www.zacks.com/ap/CATX
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。